This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jack Raphael Minchom: Innovator in APOL1 Inhibitor Development
Introduction
Jack Raphael Minchom is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of solid forms of APOL1 inhibitors. His work is crucial in addressing APOL1 mediated kidney diseases, which affect many individuals worldwide.
Latest Patents
Jack Minchom holds a patent for "Solid forms of APOL1 inhibitor and methods of using same." This patent includes novel solid-state forms of Compound I, specifically ethanol solvate Form A, ethanol solvate Form B, citric acid cocrystal Form A, and Form B. The patent also covers compositions comprising these forms and methods of making and using them, including their application in treating APOL1 mediated kidney disease. He has 1 patent to his name.
Career Highlights
Jack Minchom is currently employed at Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to treating serious diseases. His role at Vertex allows him to work on cutting-edge research and development projects that have the potential to transform patient care.
Collaborations
Throughout his career, Jack has collaborated with talented professionals, including Ales Medek and Kevin Gagnon. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical development.
Conclusion
Jack Raphael Minchom is a dedicated inventor whose work in the field of APOL1 inhibitors is making a significant impact on kidney disease treatment. His contributions to Vertex Pharmaceuticals, Inc. and his innovative patents highlight his commitment to improving healthcare outcomes.